Although several binding partners have been shown for G0S2 including Bcl2 [22], ATGL [19] and Nucleolin [29], our studies suggest that inhibition of ATGL can attenuate cell growth in a wide range of tumour cells and is an important mechanism of G0S2-mediated growth inhibition. The gene discussed is BCL2; the disease is neoplasm.